Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr:54:202-12.
doi: 10.1016/j.jbi.2015.02.004. Epub 2015 Feb 23.

Utilizing social media data for pharmacovigilance: A review

Abeed Sarker  1 , Rachel Ginn  2 , Azadeh Nikfarjam  2 , Karen O'Connor  2 , Karen Smith  3 , Swetha Jayaraman  4 , Tejaswi Upadhaya  4 , Graciela Gonzalez  2
Affiliations
Review

Utilizing social media data for pharmacovigilance: A review

Abeed Sarker et al. J Biomed Inform. 2015 Apr.

Abstract

Objective: Automatic monitoring of Adverse Drug Reactions (ADRs), defined as adverse patient outcomes caused by medications, is a challenging research problem that is currently receiving significant attention from the medical informatics community. In recent years, user-posted data on social media, primarily due to its sheer volume, has become a useful resource for ADR monitoring. Research using social media data has progressed using various data sources and techniques, making it difficult to compare distinct systems and their performances. In this paper, we perform a methodical review to characterize the different approaches to ADR detection/extraction from social media, and their applicability to pharmacovigilance. In addition, we present a potential systematic pathway to ADR monitoring from social media.

Methods: We identified studies describing approaches for ADR detection from social media from the Medline, Embase, Scopus and Web of Science databases, and the Google Scholar search engine. Studies that met our inclusion criteria were those that attempted to extract ADR information posted by users on any publicly available social media platform. We categorized the studies according to different characteristics such as primary ADR detection approach, size of corpus, data source(s), availability, and evaluation criteria.

Results: Twenty-two studies met our inclusion criteria, with fifteen (68%) published within the last two years. However, publicly available annotated data is still scarce, and we found only six studies that made the annotations used publicly available, making system performance comparisons difficult. In terms of algorithms, supervised classification techniques to detect posts containing ADR mentions, and lexicon-based approaches for extraction of ADR mentions from texts have been the most popular.

Conclusion: Our review suggests that interest in the utilization of the vast amounts of available social media data for ADR monitoring is increasing. In terms of sources, both health-related and general social media data have been used for ADR detection-while health-related sources tend to contain higher proportions of relevant data, the volume of data from general social media websites is significantly higher. There is still very limited amount of annotated data publicly available , and, as indicated by the promising results obtained by recent supervised learning approaches, there is a strong need to make such data available to the research community.

Keywords: Adverse drug reaction; Pharmacovigilance; Social media.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sample search queries used for article retrieval from Medline.
Figure 2
Figure 2
A pathway for ADR detection and extraction from social media data.
See this image and copyright information in PMC

References

    1. World Health Organization The Importance of Pharmacovigilance - Safety Monitoring of Medicinal Products. 2002 URL http://apps.who.int/medicinedocs/en/d/Js4893e/1.html.
    1. Harpaz R, DuMouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther. 2012;91(3):1010–1021. - PMC - PubMed
    1. Lazarou J, Pomeranz BH, Corey PN. Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies. JAMA. 1998;279(15):1200–1205. - PubMed
    1. Ahmad SR. Adverse Drug Event Monitoring at the Food and Drug Administration - Your Report Can Make a Difference. Journal of Internal Medicine. 2003;18(1):57–60. - PMC - PubMed
    1. Xu R, Wang Q. Large-scale combining signals from both biomedical literature and FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection. BMC Bioinformatics. 15(17) - PMC - PubMed

Publication types